Answers are grounded in this paper and cite their sources.
The CA-125 antigen is expressed on a glyco protein produced by the cells derived from the coelomic epithelium and can be detected in the pleura, pericardium, peritoneum and the Mill lerian duct derivatives.' Serum CA-125 concen tration is elevated in the vast majority of patients with ovarian cancer and has proved to be a very useful tumour marker in these patients. How ever, serum CA-125 concentrations may also be elevated in a large number of other malignant diseases such as colorectal, breast, lung and pancreatic cancer. In addition, elevated serum CA-125 concentrations may be found in other conditions, including pleural effusions and ascites irrespective of the cause. In recent years elevated serum CA-125 has also been demonstrated in patients with non-Hodgkin's Iymphoma.v? In the cases reported, no immuno reactivity for CA-125 on the lymphoma cells could be demonstrated and it was proposed that the elevated CA-125 concentration was a reactive phenomenon.t-' However, it was shown recently that lymphoma cells might secrete CA-125 under specific conditions.! We report a case which provides further evidence that high serum CA-125 concentrations in patients with malignant lymphoma may be derived from the tumour cells.
No takes yet. Share an insight, caveat, or question.
Vlasveld et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: